Mismatch endonucleases and methods of use
CA 2473187 C · Owner: Smith, Mark L. · Inventors: Smith, Mark L.; Vaewhongs, Andrew A.; Vojdani, Fakhrieh S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
We describe here restriction endonucleases and their uses. Restriction endonucleases are useful in finding single nucleotide polymorphisms. They are also useful in an in vitro method of redistributing sequence variations between non-identical polynucleotide sequences.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 31, 2003 and granted July 31, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 31, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 31, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.